The Alliance for Regenerative Medicine Welcomes Lyndsey Scull as its New Director of Communications

– December 3, 2014

WASHINGTON, DC, December 02, 2014 The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine community, has appointed Lyndsey Scull as its new director of communications.

Lyndsey comes to ARM following 10 years of global communications and public affairs work, the last five years at Hill+Knowlton Strategies where she provided strategic and political communication counsel to a variety of Fortune 500 and non-profit clients. During this time, Lyndsey worked in Dallas, Texas and Washington, D.C., and in 2013, Lyndsey relocated to the firm’s office in Kuala Lumpur, Malaysia as part of a yearlong client engagement.
“We are excited to welcome Lyndsey as a key addition to the ARM team,” said Morrie Ruffin, managing director of ARM. “As the regenerative medicine community looks towards 2015, Lyndsey’s role will be instrumental in helping to grow awareness of the field’s many advances as well as to broaden understanding of our political, educational and communication objectives.”

Lyndsey holds an MA in Global Affairs and Management from Thunderbird School of Global Management and a BA in Mass Communications from the University of Utah. She lives in Washington, D.C. with her husband.

About the Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, D.C. to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 200 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit